rolipram has been researched along with Carcinoma, Hepatocellular in 1 studies
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Massimi, M | 1 |
| Cardarelli, S | 1 |
| Galli, F | 1 |
| Giardi, MF | 1 |
| Ragusa, F | 1 |
| Panera, N | 1 |
| Cinque, B | 1 |
| Cifone, MG | 1 |
| Biagioni, S | 1 |
| Giorgi, M | 1 |
1 other study available for rolipram and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival.
Topics: Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Cycli | 2017 |